General MedicationsINTRAMUSCULARStandard

ARISTADA

ARIPIPRAZOLE LAUROXIL

Standard Dose

882MG/3.2ML (275.63MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ARISTADA is listed in Drugs@FDA under application 207533 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE LAUROXIL Form and strength SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML) Sponsor ALKERMES INC Submission history Latest submission status date: 2025-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARISTADA is listed in Drugs@FDA under application 207533 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARIPIPRAZOLE LAUROXIL Form and strength SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML) Sponsor ALKERMES INC Submission history Latest submission status date: 2025-01-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.